New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

34

Gilead’s Lenacapavir Shows Promise for Multidrug-Resistant HIV in Phase II/III Trial

Topline results from Gilead Sciences’ Phase II/III CAPELLA trial show that treatment with the company’s long-acting HIV-1 capsid inhibitor lenacapavir reduces HIV viral load better than placebo in heavily treated patients living with multidrug resistant HIV-1 infection.

37

U.S. COVID deaths top 250,000 as New York City schools halt in-person classes

The U.S. death toll from Covid-19 surpassed a grim new milestone of 250,000 lives lost as New York City’s public school system – the nation’s largest – called a halt to in-classroom instruction, citing a jump in coronavirus infection rates.

38

Liguori Academy and CMI/Compas Partner to Build Library for Students

Liguori Academy and CMI/Compas Partner to Build Library for Students PHILADELPHIA – November 18, 2020 – Liguori Academy, a nonprofit private high school committed to serving the community, has launched a campaign to build a library for its students, with the support of longtime partner CMI/Compas, strategic media agency and part of WPP (NYSE:WPP). The […]